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and the Molecular Biology Institute, University of California Los Angeles, Los Angeles,
California 90024
Summary
A family of chimeric immunoglobulins (Igs) bearing the murine variable region directed against
the hapten dansyl linked to human IgG1, -2, -3, and -4 has been characterized with respect to
binding to the human high affinity Fc y receptor, FcyR1 . Chimeric IgG1 and -3 have the highest
affinity association (Ka = 10 9 M -1 ), IgG4 is 10-fold reduced from this level, and IgG2 displays
no detectable binding. A series ofgenetic manipulations was undertaken in which domains from
the strongly binding subclass IgG3 were exchanged with domains from the nonbinding subclass
IgG2 . The subclass of the C2 domain was found to be critical for determining IgG receptor
affinity. In addition, the hinge region was found to modulate the affinity of the IgG for Fc-yR1,
possibly by determining accessibility of FcyR to the binding site on Fc . A series of amino acid
substitutions were engineered into the C.2 domain of IgG3 and IgG4 at sites considered
potentially important to Fc receptor binding based on homology comparisons of binding and
nonbinding IgG subclasses . Characterization of these mutants has revealed the importance for
FcyR1 association of two regions of the genetic C2 domain separated in primary structure by
nearly 100 residues . The first of these is the hinge-link or lower hinge region, in which two
residues, Leu (234) and Leu(235) in IgG1 and -3, are critical to high affinity binding. Substitution
at either of these sites reduces the IgG association constant by 10-100-fold . The second region
that appears to contribute to receptor binding is in a hinge-proximal bend between two a strands
within the C2 domain, specifically, Pro(331) in IgG1 and -3 . As a result of f3 sheet formation
within this domain, this residue lies within 11 A of the hinge-link region . Substitution at this
site reduces the Fc receptor association constant by 10-fold.
The antibody molecule serves as an immunologic bridge,combining in one polypeptide sites responsible for rec-
ognition offoreign pathogens and others responsible for trig-
gering ofhost response systems . IgG, the predominant form
of serum antibody, interacts through its Fc region with a
variety of host effector molecules, among which are a group
of surface receptors found on cells predominantly of hema-
topoetic origin . This Fc receptor family can be divided based
on IgG subclass specificity and mAb recognition into three
groups : FcyR types I, II, and III . FcyR1 is distinctive in
being the only receptor capable of binding monomeric IgG
with high affinity (1) .
The human Fc-yRi receptor binds ligand with the subclass
preference: IgG1, -3 > IgG4 >> IgG2 (2) . It binds murine
IgG2a, but not muIgG1 or muIgG2b, with affinity equiva-
lent to that of human IgG (3) . It has a valence for IgG of
one (4), and association of IgG with huFcyR, appears to be
mediated by a single heavy chain (5), although there are two
binding sites on each IgG molecule. FcyR1 functions
demonstrated in vitro include phagocytosis (6), and antibody-
dependent cellular cytotoxicity (ADCC)1 (7-11) . Evidence
supports a unique role for Fc-yR1 early in the immune re-
sponse before antigen-specific IgG reaches high levels .
Early attempts to localize the site on IgG responsible for
associating with huFcyR1 using proteolytic fragments of Ig
were inconclusive (12, 13) . Analysis of mutant Igs was more
informative and suggested that at least a number ofthe residues
required for association are located in the C.2 domain,
potentially in the NF12-terminal end of the domain (3) .
Examination ofa number of IgG subclasses for amino acids
Abbreviations used in this paper. Ab, antibody ; ADCC, antibody-
dependent cellular cytotoxicity; EE, exon exchange ; SDM, site-directed
mutagenesis .
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conserved among strong (Ka > 108 M-1), but not among
weak binders (K, < 106 M-1) revealed two homology
regions potentially involved in FcyR1 binding. The first is
a hexapeptide sequence in the hinge-link region immediately
before the (3 strand formation of the C.2 domain . This pep-
tide segment, conserved among huIgG1 and -3, muIgG2a,
and rabbit IgG, consists of the sequence Leu - Leu - Gly -
Gly - Pro - Ser (residues 234-239, EU numbering [141) . In
hulgG4, an intermediate affinity IgG, the sequence contains
a single amino acid substitution : Phe for Leu at position 234 .
Murine IgG2b, a weakly binding IgG, likewise contains a
single residue substitution : Glu for Leu at position 235 . In
human IgG2, which shows no binding activity, there are two
substitutions and a deletion leading to the sequence Val(234)
----- Ala(236) - Gly - Pro - Ser (Fig. 1) . The significance
of this region in mediating binding to the high affinity Fc
receptor was recently demonstrated by Duncan et al . (15),
who reported conferring IgG2a-like binding properties on
an IgG2b transfectoma protein by using oligonucleotide-
directed mutagenesis to change Glu(235) to Leu .
A second region of the C.2 domain identified by ho-
mology as a potential contributor to FcyRi binding is lo-
cated near the COOH-terminal end ofthe domain's primary
structure. This broad stretch of residues extends over two
of the three /3 strands in the Y-face of the domain, including
a hinge-proximal bend between the strands, and contains 16
residues perfectly conserved among strongly binding IgGs .
Of particular interest is the fact that among the four human
IgG subclasses, there is only one substituted site within these
conserved residues : a pair of serine residues in IgG4 replaces
Ala(330) and Pro(331) (Fig . 1) (present in the other three
subclasses) ; this difference is located in the bend between the
two (3 strands and is predicted to fold into close proximity
to the hinge-like region, although the latter is not strictly
resolved in the crystallographic Fc model due to a high de-
gree of disorder in this region of the crystal (16) .
We have taken two approaches to defining the structural
features of IgG that influence, either directly or via confor-
mational effects, the molecule's association with the human
FcyR1 . To examine the contributions made by individual
domains and by the hinge, gene manipulation has been used
to exchange exons between the four cloned human IgG con-
stant region genes . Expression of these genes in a chimeric
antidansyl system in association with the human C,r light
chain allowed the examination of intact human Ig "variant"
proteins with a series ofdomain interchanges that do not suffer
from the drawbacks of the proteolytic cleavage studies or the
uncertainties of heterologous IgG receptor systems. Studies
of natural variant proteins to date had indicated a role for
C.2 in the binding to FcyR1, but have not ruled out a con-
tribution from the C.3 domain, nor had the role of the
hinge been addressed, beyond establishing that its presence
is required for full strength binding.
On a sub-domain level, oligonucleotide-directed site-specific
mutagenesis has been used within the C,,2 domain to better
define the amino acid residues that account for the FcyR1
affinity differences between IgG subclasses. By this approach,
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we have examined residues at the NH2- and 000H-
terminal ends of the domain sequence indicated by homology
patterns tobe potentially important for receptorbinding. These
mutant IgG genes, like those of the domain-altered proteins,
have been expressed in the context of the chimeric antidansyl
system in order that homologous (human) receptor IgG in-
teractions may be investigated . These studies have indicated
the importance of residues at both ends of the C 2 domain
linear sequence in either directly contacting the receptor, or
maintaining the functional conformation ofthe binding site
(or both), and have shown that the hinge modulates the affinity
of IgG for FcyR, .
Materials and Methods
Vectors.
	
The SalI-BamHI cassette containing the constant re-
gion gene was subdoned into either pBR322 for exon exchange
(EE), or M13mp19 for site-directed mutagenesis (SDM) . EE was
performed using appropriate intronic restriction sites (e.g., PvuI),
andwas confirmed byrestriction digest analysis and double-stranded
DNA sequence analysis . SDM was performedby the double-primer
method (17) using single-mismatch oligonucleotides, and was
confirmed by sequence analysis. Mutated constant region genes were
cloned as Sall-BamHI fragments into the mammalian expression
vector pSV20Hgpt (18) with the expressed V gene from a mouse
anti-DNS hybridoma (Fig. 2) .
Transfectoma Production. The heavy chain was transfected into
the nonproducing myeloma cell line P3X63AG8.653 along with
the chimeric anti-DNS K light chain gene carried in the compat-
ible expression vector pSV184AHneo by protoplast fusion, as pre-
viously described (18) . Transfectants were selected with G418 at
1 .0 mg/ml, and surviving clones screened for antibody (Ab) produc-
tionby ELISA using DNS/BSA-coated plates. The amount ofbound
chimeric Ab was determined using alkaline phosphatase-conjugated
polyclonal goat Ab (Sigma Chemical Co., St . Louis, MO) against
human IgG constant regions . Clones producing large quantities
of anti-DNS Ab were expanded and maintained in IMDM con-
taining 5% calf serum .
Characterization of Chimeric Abp To characterize the assembly,
secretion, and molecular weight of Ig, cells were labeled with 'sS-
methionine ('SS-met) . Ab molecules in the supernatants were im-
munoprecipitated with polyclonal rabbit Ab against human Fc and
Staphylococcus aureus protein A (IgG sorb; The Enzyme Center,
Malden, MA) and analyzedby SDS-PAGE . Antibodies were purified
from culture supernatants as previously described (19) .
FcR Binding. An enzymatic assay was developed to quantitate
the binding affinities of chimeric Ab for FcyR, (20) . Human
monocyte-like U937 cells (2) were incubated with chimeric IgG
molecules at various concentrations . After a 2-h incubation, S-galac-
tosidase-conjugated DNS was added and incubated for another 2 h .
The cells were then washed by centrifugation through a sucrose
pad and a-galactosidase bound to IgG quantitated using the sub-
strate o-nitrophenyl galactoside. Scatchard analysis (21) was used
to determine the association constant of IgG to the receptor and
the number of receptors per cell .
Results
Antibody Characterization. The size ofthe H and L chains
produced by the transfectants and their assembly into H2L2
tetramers was assessed by metabolic protein labeling, followed
Figure
1
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SDS-PAGE analysis of 35S methionine-labeled chimeric IgGs .
Secreted Ig proteins were metabolically labeled with 35S-Methionine (15
pCi/ml) as described, then immunoprecipitated using rabbit anti-human
IgG Fc and S. aureus Protein A . (A) SDS-PAGE analysis of nonreduced
IgGs on a 5% acrylamide gel . Each lane is labeled above, and the migra-
tion positions of whole IgG (H2L2) and half-molecules (HL) are indicated
to the side ofthe gel . (B) SDS-PAGE analysis of reduced IgGs on a 12.5%
acrylamide gel. Lanes are labeled as in A, and the migration positions of
heavy (H) and light (L) chains are indicated to the side of the gel .
from that of the curve for IgG3 . IgG2 is not depicted in Fig .
4 because no binding of this subclass was detected at concen-
trations >100-fold higher than those used to assay IgGl .
Given the sensitivity of this assay, we estimate the K, of
IgG2 to be <106 M -1 , at least 1,000-fold reduced from the
IgGl level . Association constants for the wild-type IgGs are
given in Table 1 and represent the mean of at least three inde-
pendent assays. IgGl and IgG3 show the highest affinity for
Fc-yRI, with K, values of 109 M -1 , IgG4 is -10-fold re-
duced in binding activity, and IgG2 shows no detectable
binding by this assay (K, <106 M -1 ) . These values agree
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Table 1 . Equilibrium Binding Constants ofDomain-exchanged
Chimeric IgGs
IgGI-4, wild-type antidansyl chimeric antibodies. Mutants with exon
exchanges are given a four-digit name : the first digit refers to the sub-
class of the C 1 domain, and the second, third, and fourth digits indi-
cate the subclasses of the hinge, Ca 2, and C,,3 domains, respectively .
IgG3 OH, hinge-deleted IgG3 ; IgG3hi, IgG3 bearing a hinge encoded
by the first (unique) y3 hinge exon ; IgG3h1(2,3 .4)2, IgG3 with extended
hinge (containing a duplication of the three reiterated 73 hinge exons) .
The structure of each recombinant antibody is shown diagramatically.
Each K, value represents the mean of at least three independent trials
(± SD) . Va, exon for the heavy chain variable domain directed against
the hapten dansyl .
closely with previous reports in which the binding constants
were determined using 1251-IgG (23, 24) .
Binding ofExon Exchange Mutant to FcyR,. The role of
the constant region domains in FcyRj binding was evalu-
ated by exchanging these regions between IgG2 and IgG3
(which display opposite extremes of binding activity) . Al-
though the presence of a CH3 domain is required for Fc
receptor binding, as indicated by the fact that a myeloma pro-
tein lacking this domain shows no affinity for FcyRi (25),
this domain does not appear critical in determining the isotype-
specific binding pattern (Table 1) . The proteins denoted 2223
and 3332 represent the products of CH3 exon exchange be-
tween IgG2 and IgG3 subclasses . IgG2 bearing the C 3 do-
main of IgG3 (2223) showed no detectable binding to U937
cells (K, <106 M-1) . The reciprocal exchange, IgG3 bearing
the CH3 domain of IgG2 (3332), bound to U937 cells with
a K, equivalent to that of IgG3 (1.8 x 10 9 M -1 ), indicating
that the CH3 domain is not responsible for the subclass-
specific affinity difference between nonbinding IgG2 and the
strongly binding IgG3. Although the presence of a C3 do-
main is required for maximal binding FcyRi (as discussed
earlier), the subclass of this domain does not determine the
Immuno91.buli- "5trudure Binding Constant
K, (M -1 )
ri,~;r,r 1.2 (10.3) x 109
I 2 <1 x 106
G3 1.2(±0.5)x109
2-2-2-3 <1 x 106
3-3-3 "2 1.8 (±0.2) x 109
2 " 2-3-2 2.8 (± 1.1) x 108
3-3 " 2-2 C . .W11 <i x 106
3 " 3-2"3 <1 x 106
I G3 AH <1 x 106
IgC.IACH1 -- ~,Illllllll,r 3.0(±1.0)x107
IgG3 ACHI 2.0 (±1.2) x 108
IgG3h1 a , 2.2 (±1.3) x 108
IgG3h1(2 .3Aa ~-~ 1.8 (±0.g) x 108 ,
isotype-specific binding phenotype, suggesting that either this
domain does not directly interact with the Fc receptor or
that the interacting residues are conserved between these sub-
classes.
By contrast, the subclass of the C 2 domain does appear
to determine, by a first approximation, the binding pheno-
type of the molecule . Hence, IgG3 with an Fc region almost
completely from IgG2 (3322), and IgG3 bearing only the
C2 domain of IgG2 (3323), show no detectable binding to
U937 cells . Moreover, IgG2 with a y3 C.2 domain (2232)
binds Fc-yRj with an affinity nearly that of IgG3 (Ka = 2.8
x 108 M-1) . Interestingly, the Ka value for the protein 2232
was slightly but reproducibly lower than that of 3332 (three-
fold decreased) suggesting that the hinge and/or Cn1 do-
main may contribute to overall IgG affinity, possibly through
conformational effects on the C2 domain . Deletion of C1
altogether from IgG1 results in a decrease in association con-
stant of -30-fold (see Table 2), whereas the equivalent dele-
tion from IgG3 results in only a 10-fold reduction in Ka .
The hinge region plays a role both as a spacer region be-
tween the Fab and Fc regions and in imparting the molecule
with segmental flexibility. The presence of the hinge region
is necessary for the interaction of IgG FcyR1, and hinge-
deleted human IgG1 myeloma proteins Dob and Lec display
little binding to the mouse analogue of this receptor (26) .
IgG3 contains an extended hinge of62 amino acids, encoded
genetically by four exons (one unique, followed by three reiter-
ated exons) . As the subclass with the greatest degree of seg-
mental motion in the Fab region, IgG3 may require the ex-
tended hinge in order to prevent steric hindrance to close
approach of effector molecules . As shown in Table 1, dele-
tion of the entire hinge (IgG3AH) results in complete loss
of binding to the human FcyR,, in agreement with the
studies of Dob and Lec . Partial replacement of the hinge with
a 17-residue segment encoded by the first (unique) IgG3 hinge
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Figure 4 . Scatchard plots of the binding of wild-type IgG to U937 cells . (A) The effect of human IFN-y on binding of IgG3 . Binding was assayed
on untreated cells (open triangles) and on cells treated with 100 U/ml of human rIFN-y for 18 h (filled triangles) . IFN-y increases the number of Fc
receptors per cell (represented by x-intercept) but does not affect the affinity ofinteraction (represented by the absolute value of the slope in each plot) .
In this case untreated cells yielded 3,400 receptor sites per cell ; IFN-y-treated cells, 19,000 site per cell . (B) Comparison of IgG1 and IgG3 binding
by IFN-y treated U937 cells. IgGI, filled squares ; IgG3 filled triangles . These two proteins display equivalent affinities for Fc7Rj (parallel Scatchard
plots); the variance in receptor number estimated per cell (IgG1, 34,000 ; IgG3, 19,000) is not uncommon between assays and is most likely due to
differences in cell culture conditions immediately before assay. (C) Comparison of IgG3 and IgG4 binding to U937 cells not treated with IFN-y .
The decreased affinity of IgG4 for FcyR, relative to IgG3 is represented by the difference in slopes of the two plots . IgG3, open triangles ; IgG4, open
circles . R, number of IgG molecules bound per cell; R/IgGf, the ratio of IgG molecules bound to free IgG.
exon results in restoration ofreceptor binding, however, this
protein (IgG3h1) displays a K, value 10-fold reduced from
wild-type (K, = 2.2 x 108 M -1 ) (Table 1) . Therefore,
IgG3ht, which exhibits segmental flexibility equivalent to
wild-type IgG3, is reduced in ability to fix complement and
bind Fc-yRj supporting a role for the extended hinge in
preventing steric hindrance. Somewhat surprisingly, IgG3
bearing a hinge extended by duplication ofits reiterated exons
(IgG3h1(2,3,4,)2) also exhibits -10-fold reduced affinity for
Fc-yRj relative to IgG3; therefore, there is an optimal
spacing between Fab and Fc .
Amino Acid Substitutions. Having established the impor-
tance of the C 2 domain of IgG in the interaction with
FcyRj on U937, we next investigated the contributions to
Table 2 . Equilibrium Binding Constants of Amino
The name of each mutant indicates its subclass, the position of the amino
acid substitution (EU number system), and the amino acid created at that
site . IgG4 (Leu[2341) Hy3 represents IgG4 substituted at position 234
(Leu for Phe) and bearing the hinge of IgG3 . Each K, value, represents
the mean of at least three independent trials ( ± SD) .
Acid-substituted Chimeric IgGs
IgG K,
M-4
IgG3(Glu[235]) <1 x 10 7
IgG3(Phe[234]) 1 .9 ( ± 0.8) x 10,
IgG4(Leu[234]) 3 .8 (± 1 .4) x 108
IgG3(Ser[331]) 3.1 (± 2.6) x 10,
IgG4(Leu[234], Pro[331]) 1.3 (± 0.4) x 108
IgG4(Leu[234])H-Y3 1 .0 (± 0.2) x 10,
binding made by selected residues within the domain, using
oligonucleotide-directed mutagenesis to produce amino acid
substitutions . Table 2 lists a series of site-specific mutant IgG
proteins and the associated K, values for binding U937 cells.
The first substitutions introduced were designed to examine
the role of the homology region (identified by Woof et al .
[25]) encoded at the 5' end of the C2 exon, and falling in
the hinge-link region of the molecule (Fig . 1) . As discussed
earlier, this conserved hexapeptide consisting of Leu(234) -
Leu - Gly - Pro - Ser(239) is present in human IgG1 and IgG3,
is substituted once at residue 234 by Phe in IgG4, and once
at residues 235 by Glu in muIgG2b. A single amino acid sub-
stitution in the hinge-link region ofmouse IgG2b, Glu(235)
to Leu, increased the binding of this Ig >100-fold, to a level
equivalent to that of human IgG1 (15) . We have found that
the reciprocal substitution ofGlu for Leu(235) in IgG3 leads
to a significant decrease in FcyR affinity (Table 2) . How-
ever, our studies make it clear that in human IgG more than
one residue determines Fc receptor binding affinity, and that
the critical residues are not all contiguous in the primary se-
quence .
Human IgG4 differs in the hinge-link region from the high
affinity subclasses (IgG1 and -3) at only one position : Phe
replaces Leu(234) . To evaluate the role played by this amino
acid in determining the relatively low binding affinity of IgG4
for the receptor, the reciprocal substitution of Leu and Phe
was performed between IgG3 and IgG4 at this position . IgG3
(Phe234) is reduced in association constant (Table 2) to the
level of IgG4 (K, = 1.9 x 108 M-1), indicating that res-
idue 234, like residue 235, is important in receptor binding.
The reciprocally substituted protein, IgG4 (Leu[234]) exhibits
increased affinity for FcyR1, however, the binding affinity
does not reach the level of IgG3 (Table 2) . Apparently, other
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aspects of the IgG4 molecule, potentially masked by the nega-
tive contribution ofPhe(234), affect antibody receptor inter-
actions. Sequence comparison reveals that among the CH2
residues conserved in strongly binding IgG subclasses (human
IgG1, -3, mouse IgG2a), IgG also differs at residues 330 and
331 . These residues are within a hinge-proximal bend be-
tween two /3 strands of the C.2 domain predicted to fold
in close proximity to the hinge-link region (Fig . 5) . In IgG3,
residues 330 and 331 are Ala and Pro, respectively; in IgG4,
these are replaced by Ser-Ser, and in mouse IgG2b, by Ser-
Pro. In as much as the affinity of IgG2b can be increased
to the level of IgG3 by a single amino acid substitution in
the hinge-link region, the presence of serine at position 330
does not appear detrimental to receptor interaction. To evaluate
the role of Ser(331) in the binding affinity for Fcyk,, a
second substitution was made in the mutant IgG4(Leu[234])
generating IgG4(Leu[234], Pro[331]) ; a reciprocal mutation
was generated in IgG3 yielding IgG3(Ser[331]) .
IgG3(Ser[331]) is reduced in affinity for FcyR1 by a factor
of 10, indicating that Pro(331), like Leu(234) and Leu(235),
is important for high affinity receptor association (Table 2) .
Curiously, the double-mutant IgG4(Leu, Pro) shows no im-
provement in K, relative to IgG4(Leu[234]), and in fact ap-
pears reduced in affinity, indicating that the appropriate com-
bination of factors for high affinity binding still has not been
achieved.
Another feature ofthe IgG4 molecule that might contribute
to its reduced affinity relative to IgG3 is its hinge, which
is relatively rigid. To evaluate the possibility that the mutant
IgG4(Leu[234]) is reduced in K, relative to IgG3 due to the
stiff nature of its hinge region, the hinge of IgG4(Leu[234])
was replaced with a y3 hinge, yielding the antibody
IgG4(Leu[234])Hy3 . As indicated in Table 2, however, the
Figure 5 .
	
Graphic representation of
the Fc region of IgG. C.2 is shown in
yellow, C 3 and the C.2-linked carbo-
hydrate are in white. Pro 238 is red, Pro
331 is magenta, with the rest of the loop
from 328 to 333 shown inblue. Ala 327
is light blue-green. The coordinates are
from Diesenhofer (16) ; the graphic was
made using the Maclmdad computer
graphics package . The two Fc regions
face in opposite directions, therefore, the
residues visible on the right domain are
invisible on the other side of the left
domain.
hinge substitution does not improve binding affinity. Like
the double-mutant IgG4(Leu, Pro), IgG4(Leu[234]), Hy3
exhibits a K, value reduced 10-fold from the level of IgG3 .
There are several conclusions that can be drawn from these
results. The association of IgG with FcyR, is directly
influenced by multiple amino acid residues in the C2 do-
main. These residues are not limited to the peptide segment
defined by Duncan et al . (15), but are also found in a hinge-
proximal bend formed between two /3 strands in the globular
domain structure (Fig. 5) . Since these residues all lie within
close proximity, they may all contribute directly to receptor
association. In addition, the hinge region appears to modu-
late receptor affinity. Since molecules bearing hinges varying
widely in length and sequence all show reasonable binding
affinity (K, > 10 8 M -1), it seems likely that the hinge does
not play a direct role in receptor interaction but instead exerts
a conformational effect and, by controlling the spacing of
the Fab and Fc regions, determines the accessibility of the
receptor binding site on the Fc .
Discussion
The mutational analysis used in this work to investigate
the interactions of IgG with its high affinity receptor represents
a powerful technique for discerning the contributions made
by various regions of the molecule to overall effector func-
tion activity. The anti-DNS chimeric antibody system makes
this approach possible by linking the cloned human y and
K constant region genes to their respective murine H and L
chain variable region genes in an expression system that yields
mAb production in transfected myeloma cells . The relative
facility with which these cloned genes can be manipulated
and expressed provides the unique opportunity to focus at-
tention on a particular region within the IgG molecule, while
operating in the context of the whole polypeptide. The use
of mutagenesis to isolate regions functionally without re-
quiring physical isolation (e.g., by fragmentation) allows for
the correlation of structure with function without artifacts
introduced by loss of native conformation . Chimeric Igs have
normal Ig function and, indeed, the values we obtain for the
association constants ofIgG1, -3, and -4 binding to the mono-
cyte receptor on U937 cells are in agreement with previous
published reports (23) .
The relative FcyR affinities of the mutant antibody pro-
teins examined here offer a number of insights into the role
of IgG structure in effector function . The association con-
stants of IgG2 and IgG3 are unaltered by exchange of the
C 3 domain between the subclasses, indicating that the
structural basis for the nonbinding phenotype of IgG2 does
not reside in the COON-terminal domain . Likewise, the fea-
tures of the IgG3 molecule that confer on it high affinity
for Fc7Rj are not contained within the C.3 domain. Ad-
mittedly, this analysis is limited to localizing the structural
differences between proteins responsible for variations in func-
tional efficiency. To the extent that the C3 domains of IgG2
and IgG3 contribute equally to receptor binding, the degree
to which they contribute may not be determined. Compar-
ison of the amino acid sequences of the C3 domains in
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IgG1, -2, -3, and -4 (14) reveals 11 positions at which the
four subclasses are not identical. However, only one site of
sequence difference between subclasses, located three residues
from the COOH terminus of the C3 domain, is likely to
be solvent accessible. As this residue is shared by IgG1, -2,
and -3 (Pro) but differs in IgG4 (Leu), it could conceivably
contribute to the reduced affinity of IgG4. Though it is im-
possible to rule out this contribution without specifically sub-
stituting this residue, its position relative to C2 residues,
shown by us and others (15) to be critical to FcyRj binding,
makes it an unlikely candidate for a role in receptor binding.
We therefore conclude that the C3 domain of IgG does not
contribute to the FcyR affinity differences displayed by the
subclasses.
The hinge region imparts segmental flexibility to IgG.
Among the human IgG subclasses, IgG3 stands out as pos-
sessing the most radically different hinge structure and dis-
plays the greatest segmental flexibility (27) ; the exceptional
flexibility ofIgG3 is mediated by that region encoded by the
first (unique) hinge exon (22) . The requirement of a hinge
per se for full effector function activity has been demonstrated
for IgG1 using the hinge-deleted myeloma variants Dob and
Lec; in these proteins, the close contact of CL and C2 do-
mains emphasizes the role of the hinge as a spacer between
Fab and Fc. Likewise, in IgG3, deletion of the hinge region
altogether abrogates FcyRi binding (as well as complement
fixation [22]) . Unlike IgG1, however, IgG3 appears to re-
quire a long spacer for full effector function . Hence, IgG3
bearing a hinge of 17 amino acids encoded by hinge exon
1, but lacking the rigid spacer encodedby the repetitive exons
2, 3, and 4, is reduced in affinity for FcyRi . We propose
that the added Fab flexibility mediated by the IgG3 upper
hinge would permit close approximation of the Fab arms and
the FcyRj contact site were it not for the added distance
provided by the extended hinge ; thus, high Fab flexibility
in IgG3h1 may sterically compromise Fc receptor access to
its binding site. It should be noted that the amino acid com-
position ofhinge segment 1 is different from that ofthe reiter-
ated segments normally abutting the hinge-like region, how-
ever, five amino acids most proximal to the hinge-link are
identical in all four hinge segments, and in fact, represent
the conformationally constrained spacer unit (Cys - Pro - Arg
- Pro) . Interestingly, when the hinge reaches a certain length,
added spacing appears detrimental to effector function, perhaps
because offlexion in the polyproline helix. Hence, IgG3 with
a hinge of 117 amino acids is compromised in its affinity for
FcyR,, as well as in its ability to consume complement (22) .
The role of the C1 domain in the association of IgG
with human high affinity receptor appears to be limited to
maintenance of overall quaternary structure since the Fc re-
gion alone shows full binding capacity. The requirement for
this domain for full strength binding to FcyRi may repre-
sent the effects of steric hindrance on antibody receptor in-
teraction by the Crc domain, without an analogous C do-
main with which to pair in these mutants . Both IgGAC1
and IgG3AC1 show reduced affinity for FcyR, with
IgG10C 1, showing the most profound reduction. The Pat-
tern ofH-L disulfide bridging differs between IgG1 and IgG3:
the light chain in IgG1 bonds to the NH2-proximal cysteine
residue in the hinge region, whereas in IgG3 this bond is
to a cysteine residue in the C1 domain . Based on these pat-
terns, it seemed likely that the assembly of IgG3 would be
more disturbed by the C1 deletion than that of IgG1. In
fact, the contrary was observed. Apparently, in IgG3ACH1,
the L chain is able to use one of the 11 cysteine residues in
the extended hinge to form the H-L bridge. Electromicro-
graphic studies (V Schumaker, unpublished results) have shown
that the extended hinge of IgG3 is about the same size as
a domain, and apparently the hinge can assume some of
the roles played by C 1 in the C1-deleted molecule. In
IgG10C 1, on the other hand, the hinge is much shorter,
and apparently Crc cannot assume a conformation suitable
for disulfide bonding with this hinge . Hence, IgG3AC1 is
secreted predominantly as covalent H2L2 tetramers, whereas
IgG10C  1 is secreted primarily as covalently linked H chain
dimers.
The IgG region most clearly implicated in direct binding
of the human FcyRi is the C 2 domain . Binding phenotype
is transferred with this domain in exchanges between binding
and nonbinding subclasses. Hence, IgG2 bearing the C.2
domain of IgG3 is improved at least 300-fold in receptor
affinity. Though the mutant 2232 did not display IgG3-level
Fc-yR, affinity, this is not entirely surprising considering the
conformational contributions to Fc function made by the hinge
region .
Intradomain substitutions within C 2 itself identify two
regions of the primary structure as contributing to the differen-
tial subclass affinities for FcyR,. The pair of leucine residues
in the hinge-link region (positions 234 and 235, EU num-
bering system) shared among all high affinity IgGs examined
are critical to Fc receptor association, since substitution of
either of these residues with the amino acid present in sub-
classes of reduced affinity results in reduction of K, . Leu
(bearing a branched hydrocarbon side chain) is replaced by
a Glu residue (bearing a negatively charged side chain) at po-
sition 235 in muIgG2b . The introduction of a charged res-
idue at this site may interrupt hydrophobic interactions critical
to receptor association, resulting in the severely compromised
binding affinity of this Ig (>100-fold reduced relative to the
strongly binding subclasses, hulgG1, -3, muIgG2a) . In human
IgG4, on the other hand, Leu is replaced by Phe (bearing
an aromatic side chain) at position 234 . The introduction
of a bulky aromatic group in this position may cause steric
hindrance of the IgG-FcyRj interaction, however, the non-
polar environment of the region is maintained . This distur-
bance appears less severe than that caused by the Glu for Leu
substitution, since IgG4 is reduced in binding affinity only
10-fold relative to the strongly binding subclasses .
Residue 331 (Pro in IgG1 and -3), near the COOH-terminal
end of the domain sequence, also appears directly involved
with receptor interaction, since Fc-yR, association is highly
sensitive to substitution at this site . Though separated by 96
residues in linear sequence, these two sites are in fact quite
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close in space due to the tertiary structure of the C2 do-
main (Fig. 5) . Examination of the crystallographic structure
of FcyRI by computer graphics using the atomic coordinates
of Deisenhofer (16) reveals that residue 331 lies in a peptide
loop between two (3 strands, at the hinge-proximal end of
the domain . Though the hinge-link region is not resolved
due to a high degree of disorder at this site in the crystal
structure, Pro(331) folds into close proximity with Pro(238)
(the first resolvable residue in the Fc) of the hexapeptide
L - L - G - G - P - S discussed earlier (<11 A between
a-carbon atoms) (see Fig. 5) . Our findings represent the first
experimental evidence that the hinge-link region and hinge-
proximal bend may function together in binding the human
high affinity Fc receptor. These two regions may serve as con-
tact points for receptor association, or alternatively, one re-
gion may be critical for stabilizing peptide conformation in
the other region, allowing FcyR, proper access . A puzzling
issue is why the Phe(234) and Pro(331) substitutions do not
restore maximal binding to IgG4 . IgG2 and IgG4 differ from
IgG1 and IgG3 at amino acid 327 (light blue-green in Fig. 5) ;
this residue is Gly in IgG2 and -4, and Ala in IgG1 and -3 .
Residue 327 is not completely conserved for it is Asp in mu-
rine IgG2b, and that substitution does not appear to com-
promise FcyRj binding . The Ala, Gly substitution would
be highly conservative, however, the Gly substitution may
impart additional mobility to the 328-333 bend and this mo-
bility may impair binding.
Our results do not delimit the extent of FcyRi-
interacting residues . Indeed, Woof et al. (25) have pointed
out that the COOH-terminal 20-30 residues of C2 show
numerous sites of identity between IgGs with high affinity
for Fc-yR, . Most of these sites extend along two of the three
a strands in the Y-face of the domain, with Pro 331 falling
at the bend between the strands . Thus, with regard to prox-
imity of these residues to the hinge-link region, residue 331
and those neighboring it (Fig. 5) appear the most likely can-
didates for receptor interaction . Clearly, more site-specific sub-
stitution will be required to further delimit the residues crit-
ical to high affinity binding.
Clearly, multiple features of the IgG molecule influence
its interaction with FcyRI . In the divergent evolution of the
four human IgG subclasses, factors making negative and posi-
tive contributions to binding have been sorted to yield the
present binding phenotypes . Reduction ofaffinity may follow
a single alteration in a structural feature required for receptor
association, as demonstrated by the Glu(235) or Ser(331)
substitutions of IgG3 . On the other hand, increasing binding
affinity may require an appropriate combination of features
(e.g., the high segmental flexibility of IgG3 matched with
the long hinge of this molecule) before an observable im-
provement is achieved . This may explain the seemingly para-
doxical results obtained with the IgG4 substitutions mutants .
Engineering antibodies with desired receptors binding prop-
erties may require a combination of the proper structural al-
terations.
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